Dexycu

dexamethasone intraocular suspension · EyePoint Pharmaceuticals

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Dexycu, covering 2018-02-09 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery [Phase 4]